Radiopharmaceutical Contract Manufacturing
Pioneering the Next Generation of Theranostics. SOFIE is committed to the future of disease-specific tracers and companion therapeutics. Our efforts are focused in two key areas. We are working with pharmaceutical, biotech, and academic community partners in the development of new, targeted molecular tracers employing high resolution PET/CT technology and designed to provide accurate, specific diagnostic information for physicians. SOFIE has a full range of radiopharmaceutical development services for diagnostic and therapeutic compounds from R&D, clinical trials, and commercial manufacturing stages. SOFIE relies on its proven expertise of developing, registering, and supplying radiopharmaceuticals under strict 21 CFR 211 and 212 CGMP standards to be the partner of choice for your new tracer or therapeutic.
Please download our brochure below or click here to contact us for more information.